Hemagglutination-Inhibition Titer

Figshare2015-12-02 更新2026-04-29 收录

流感疫苗免疫原性

血凝抑制试验抗体滴度

数据链接：

https://figshare.com/articles/dataset/_Hemagglutination_Inhibition_Titer_/609072 数据链接链接失效反馈

官方服务：

资源简介：

aDose based upon HA contentbInfluenza viruses used in the HAI assay against sera collected at week 5.cHAI GMT plus or minus SEM.dVLP vs. rHA comparing same dose, t-test, *p

创建时间：

2015-12-02

DataSheet_1_Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab.pdf

多发性硬化症免疫学

流感疫苗免疫原性

IntroductionGiven the varying severity of coronavirus disease 2019 (COVID-19) and the rapid spread of Severe-Acute-Respiratory-Syndrome-Corona-Virus-2 (SARS-CoV-2), vaccine-mediated protection of part

NIAID Data Ecosystem70

DataSheet_1_Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine.pdf

流感疫苗免疫原性

感染后免疫应答

Public health vaccination recommendations for COVID-19 primary series and boosters in previously infected individuals differ worldwide. As infection with SARS-CoV-2 is often asymptomatic, it remains t

NIAID Data Ecosystem10

Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants

流感疫苗免疫原性

疫苗加强针效果评估

Safety and immunogenicity of a broad-spectrum mosaic vaccine as a booster dose against SARS-CoV-2 Omicron and other circulating variants

NCATS Open Data2022-09-16 更新00

Immunogenicity of the reassortant H5N1 virus against homologous and heterologous clade viruses.

流感疫苗免疫原性

病毒分支交叉保护

Immunogenicity of the reassortant H5N1 virus against homologous and heterologous clade viruses.

NIAID Data Ecosystem30

Dataset from Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (GSK2340272A) in Children Aged 3 to 9 Years

疫苗临床试验

流感疫苗免疫原性

The objective of this study is to evaluate the safety and immunogenicity study of GSK Biologicals' pandemic influenza candidate vaccine (GSK2340272A) in children aged 3 to 9 years.

NIAID Data Ecosystem00

Hemagglutination-Inhibition Titer

资源简介：

相关数据集